TREA

79401832 - 3DµS

Follow

Information

  • Trademark
  • 79401832
  • Serial Number
    79401832
  • Registration Number
    7862559
  • Filing Date
    February 22, 2024
    a year ago
  • Registration Date
    July 15, 2025
    4 months ago
  • Transaction Date
    July 15, 2025
    4 months ago
  • Status Date
    July 15, 2025
    4 months ago
  • Published for Opposition Date
    April 15, 2025
    7 months ago
  • Location Date
    July 15, 2025
    4 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    LAM, HAI-LY
  • Attorney Name
    Alex Patel
  • Owners
Information
Mark Drawing Code
3
Mark Identification
3DµS
Case File Statements
  • DM0000: The mark consists of the stylized wording "3DµS".
  • GS0071: Machines for the pharmaceutical processing industry, namely, print heads for 3D printers for drugs and vaccine preparations, print heads for pharmaceutical drug and vaccine printing machines, industrial robots for conveying of drugs and vaccine preparations, and packaging machines for drugs and vaccine preparations; machines for the pharmaceutical processing industry, namely, for producing drug and vaccine capsules and tablets and mixing machines for drugs and vaccines; 3D printers; 3D bioprinters
  • GS0051: Veterinary preparations, namely, veterinary vaccines, greases for veterinary purposes, antibiotics for veterinary purposes, bacterial preparations for veterinary purposes, veterinary diagnostic reagents, antibodies for veterinary purposes, and anti-infective products for veterinary use; dietetic foods adapted for medical purposes; sugar for medical purposes; dental resin for temporary bridges, crowns and veneers; pharmaceutical preparations for the treatment of bone diseases; biological tissue cultures for medical purposes; fever blister treatment preparations; dysmenorrhea treatment preparations; pharmaceutical preparations for the central nervous system; oral analgesics; anticoagulants; tumor suppressing agents; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for inducing erections; stimulants for the central nervous system; pharmaceutical preparations for treating allergies; anti-diabetic pharmaceuticals; calcium channel blockers; medicinal preparations for the mouth to be applied in the form of tablets; pharmaceutical preparations for the prevention and treatment of cancer; niacinamide preparations for the treatment of acne; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating hypoglycemia; antihypertensives; chemotherapeutics; antivirals; anti-infectives; chemico-pharmaceutical preparations for the treatment of cancer, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases, genitourinary diseases, neurological diseases, immune system related diseases, gastrointestinal diseases, musculoskeletal diseases and endocrine metabolism-related diseases; living cells for medical use; parathyroid hormone preparations; contraceptive preparations; medicines for the treatment of cardiovascular and cerebrovascular diseases; hypnotic sedatives; pharmaceutical products for treating respiratory diseases
  • PM0001: 3DµS; 3D MU S; 3D MICRO S; THREE DS
  • GS0421: Scientific research for medical purposes in the field of cancerous diseases; pharmaceutical research services; testing of pharmaceuticals; research and development services in the field of medicines; development of pharmaceutical preparations and medicines; pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; technical research in the field of pharmaceutical studies; quality testing of pharmaceutical product; advisory services relating to material testing
Case File Event Statements
  • 8/8/2024 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 8/15/2024 - a year ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 8/19/2024 - a year ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/19/2024 - a year ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/11/2024 - a year ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/13/2024 - a year ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/14/2024 - a year ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/16/2024 - a year ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/17/2024 - a year ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/8/2024 - a year ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 12/20/2024 - 11 months ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/20/2024 - 11 months ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/20/2024 - 11 months ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/17/2025 - 10 months ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 1/17/2025 - 10 months ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 2/24/2025 - 9 months ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/24/2025 - 9 months ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 2/24/2025 - 9 months ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/17/2025 - 10 months ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 2/25/2025 - 9 months ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/25/2025 - 9 months ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/25/2025 - 9 months ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/25/2025 - 9 months ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/15/2025 - 7 months ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/21/2025 - 8 months ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/9/2025 - 8 months ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/25/2025 - 5 months ago
    29 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 7/15/2025 - 4 months ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/15/2025 - 4 months ago
    31 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/15/2025 - 7 months ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/15/2025 - 6 months ago
    28 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF